Abstract:Abstract Introduction Sleepiness, a common symptom of various sleep disorders, has been subjectively measured using the Epworth Sleepiness Scale (ESS) and objectively quantified using the Psychomotor Vigilance Test (PVT). The relative merit of these two measures of sleepiness has been debated, and both have shown inconsistent relationships with severity of obstructive sleep apnea (OSA) and responses to treatment. We report the relative associations of ESS and PVT with hours of CPAP use within a clinical sample. Methods Patients being evaluated for sleep disorders at the University of Pennsylvania’s Sleep Center competed both the ESS and PVT measurements in a single clinical visit. Thirty-nine patients had a diagnosis of OSA and were currently using CPAP. Pearson’s correlations were utilized to examine the association between CPAP adherence and both the ESS and PVT measures (transformed lapses [sum of square root of number of lapses and square root of lapses+1]) and mean reciprocal response time (RRT). Results total of 39 patients (64.1% males; 52.6% White, 39.5% Black) were studied, with a mean (SD) age of 61.1 (16.4) years and BMI of 35.2 (9.5) kg/m2; residual apnea-hypopnea index (AHI) was 6.5 (10.8) events/hour (23 [63.9%] had residual AHI < 5 events/hour). Participants used CPAP an average of 5.87 (2.27) hours/night in the past 30 days, 5.87 (2.47) hours/night over the past 7 days, and 5.91 (2.86) hours/night the day prior to ESS/PVT measurement. Overall, we observed a strong correlation between less subjective sleepiness based on ESS and more CPAP usage at 30-days (rho = -0.48, p=0.002), 7-days (rho = -0.43, p=0.006) and the prior day (rho = -0.38, p=0.017). However, there was no correlation between hours/night of CPAP adherence and objective function as measured on PVT. Conclusion Among patients with OSA using CPAP evaluated at University of Pennsylvania’s Sleep Center, greater amounts of CPAP use were significantly associated with lower ESS scores (e.g., less sleepiness). Conversely, no significant correlations were observed between CPAP use and objective data on PVT. Larger studies examining the causal effects of CPAP on subjective and objective sleepiness, including with repeat assessments of ESS and PVT during therapy, are warranted. Support (if any)

Clinical Characteristics of Obstructive Sleep Apnea Patients with Residual Sleepiness

0764 Clinical Phenotypes of Patients with Obstructive Sleep Apnoea: A Retrospective Study

Characteristics of Patients With Severe Obstructive Sleep Apnea Who Maintain Slow-Wave Sleep

Characterization of primary symptoms leading to Chinese patients presenting at hospital with suspected obstructive sleep apnea.

Mutagenicity of N-nitrosodiethanolamine in a V79-derived cell line expressing two human biotransformation enzymes.

A real-world observational study assessing relationships between excessive daytime sleepiness and patient satisfaction in obstructive sleep apnea

Evaluation of the Risk Factors of Depressive Disorders Comorbid with Obstructive Sleep Apnea

Phenotyping patients treated for obstructive sleep apnea with persistent objective impaired alertness or subjective sleepiness

0955 Correlation Between CPAP Use and Symptoms of Depression, Anxiety, and Sleepiness in Patients with OSA

Effect of Depressive Symptoms on the Adherence to Continuous Positive Airway Pressure in Obstructive Sleep Apnea Patients Using a Path Analysis-based Approach

Cytoarchitecture of the medial geniculate body and thalamic projections to the auditory cortex in the rufous horseshoe bat (Rhinolophus rouxi)

Residual excessive daytime sleepiness in patients treated for obstructive sleep apnea: guidance for assessment, diagnosis, and management

[Research in orthopedics: is it worth the effort?].

0560 CPAP Effect on Energy Expenditure, Intake, Body Composition, and Sleep Patterns: A Randomized Controlled Trial

An innovative phonological therapy programme.

0571 Impact of CPAP Adherence on Objective and Subjective Sleepiness Measures

Excessive Daytime Sleepiness in Depression and Obstructive Sleep Apnea: More Than Just an Overlapping Symptom

Synthesis and antidepressant properties of novel 2-substituted 4,5-dihydro-1H-imidazole derivatives.

Development of Miliary Tuberculosis under Infliximab in a Patient with Spondyloarthritis and Suspected Crohn’s Disease

Obstructive Sleep Apnea With or Without Excessive Daytime Sleepiness: Clinical and Experimental Data-Driven Phenotyping

Cognitive Effects of Treating Obstructive Sleep Apnea: A Meta-Analysis of Randomized Controlled Trials